Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fontus Pharmaceuticals is a specialty pharmaceutical company headquartered in Birmingham, Alabama, dedicated to providing high-quality prescription products to the healthcare market. The company's primary focus is on the hematology sector, specifically addressing iron deficiency and anemia through its flagship product, Ferralet 90. Fontus was established by an experienced leadership team with a proven track record in the pharmaceutical industry, including the successful development of previous ventures like Cypress Pharmaceutical. The company utilizes a targeted commercialization strategy to deliver value-driven therapeutic solutions to patients and providers. By focusing on niche specialty markets, Fontus aims to improve patient outcomes with reliable and accessible medication options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fontus Pharmaceuticals.